Skip to main content

1 Result(s)

within Article Remove this filter S Tartas Remove this filter

and

  1. No Access

    Article

    Rituximab-related late-onset neutropenia after autologous stem cell transplantation for aggressive non-Hodgkin's lymphoma

    Rituximab, an anti-CD20 monoclonal antibody, is increasingly used in the treatment of B-cell non-Hodgkin's lymphoma. Late-onset neutropenia in relation to rituximab has been recently described. In this report,...

    B Lemieux, S Tartas, C Traulle, D Espinouse, C Thieblemont… in Bone Marrow Transplantation (2004)